← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vascumab, Llc
Branford, CT
$1,183,990
Total funding
3
Grants
Funding over time
peak $583.2K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$1,183,990 · 3
By mechanism
N01$600,749 · 1
R43$583,241 · 2
Investigators at Vascumab, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF HDAC INHIBITORS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - VITA 2$405,821
N01 · FY2017 · HL
Small Molecule Apelin Receptor agonists for teh treatment of Heart Failure in PAH$310,197
R43 · FY2019 · HL
GALC Pharmacological Chaperone Drugs for Krabbe Disease$273,044
R43 · FY2019 · HD
HDAC INHIBITORS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, VITA 2$194,928
N01 · FY2018 · HL